CS239438B1 - 2-alyftio-benzoylamino-672 / benzothiazole - Google Patents
2-alyftio-benzoylamino-672 / benzothiazole Download PDFInfo
- Publication number
- CS239438B1 CS239438B1 CS844605A CS460584A CS239438B1 CS 239438 B1 CS239438 B1 CS 239438B1 CS 844605 A CS844605 A CS 844605A CS 460584 A CS460584 A CS 460584A CS 239438 B1 CS239438 B1 CS 239438B1
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- compound
- benzothiazole
- chlorobenzoylamino
- benzoylamino
- mercaptobenzenethiol
- Prior art date
Links
Landscapes
- Thiazole And Isothizaole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Doteraz neznány 2-alyltio-6-(2-chlórbenzeylamlnejbenzetiassl vzorca Zlúčenlna sa připravuje alkyláclou draselnej seli 6-(2-chlerbenseylamine)-2- -merkaptebensetlazelu alylbremidem. Zlúčenlna padla vynálezu je antimykobakteriélne účinná preti tuberkulóznyn mykebaktáriám, najma preti atypickým kmenem M. fertuitum, 11. avium a M. kanaasli; metne ju používat ake účinnú Blažku entimykebekteriálnych prípravkov alebe ake medsipredukt pre dalSle syntézy.The previously unknown 2-allylthio-6-(2-chlorobenzylamine)-2-mercaptobenzenethiol of the formula is prepared by alkylation of the potassium salt of 6-(2-chlorobenzylamine)-2-mercaptobenzenethiol with allyl bromide. The compound of the invention is antimycobacterially effective against tuberculosis mycobacteria, especially against atypical strains of M. fertuitum, M. avium and M. canasli; it can be used as an effective component of antimycobacterial preparations or as an intermediate for further syntheses.
Description
(54) 2-alyftio-672-chlórbenzoylamino/benzotiazol(54) 2-Allyphthio-672-chlorobenzoylamino / benzothiazole
Doteraz neznány 2-alyltio-6-(2-chlórbenzeylamlnejbenzetiassl vzorcaSo far unknown 2-allythio-6- (2-chlorobenzylaminobenzetiassl)
Zlúčenlna sa připravuje alkyláclou draselnej seli 6-(2-chlerbenseylamine)-2-merkaptebensetlazelu alylbremidem. Zlúčenlna padla vynálezu je antimykobakteriélne účinná preti tuberkulóznyn mykebaktáriám, najma preti atypickým kmenem M. fertuitum,The compound is prepared by alkylating potassium sele of 6- (2-chloro-benzylamine) -2-mercaptebensetlazel with allyl bromide. The compound of the invention is antimycobacterially active against tuberculous mycebactaria, in particular the atypical strain of M. fertuitum,
11. avium a M. kanaasli; metne ju používat ake účinnú Blažku entimykebekteriálnych prípravkov alebe ake medsipredukt pre dalSle syntézy.11. avium and M. kanaasli; Use it as an effective blend of entimycebecterial preparations or as a medsipreduct for other syntheses.
23943«23943 «
Predmetom vynálezu je 2-alyltio-6-(2-chlórbenzoylezdno)benzotiazol. Nechlorovaný analog zlúčeniny podlá vynálezu, 2-slyltio^-benzoylominobenzotiazol (Sidrfová, Ϊ. a Odlerová, 2., čel. AO 225015 (1983)), ako aj východisková látka pra jaj eyntázu, 6-(2-chlorbenzoylamino)-2-benzotiazolíntlón (Sldóová, X. a Odlarová, 2., čel. AO PV 4606-84) oú antimykobakteriálne účinné. *The present invention provides 2-allylthio-6- (2-chlorobenzoyl) benzothiazole. Non-chlorinated analogue of the compound of the invention, 2-slythio-4-benzoylominobenzothiazole (Sidrf, a and Odler, 2nd, ref. AO 225015 (1983)), as well as the starting material for eynthase, 6- (2-chlorobenzoylamino) -2- benzothiazolinone (Sldó, X. and Odlar, 2nd, Fac. AO PV 4606-84) are antimycobacterially active. *
Teras sae zlatili, Se doteraz nesnáma zlúčenina vzorcaThe compound of the formula is not yet known
CO —NH ClCO — NH Cl
je účinná proti typický· tuberkulozny· mykobaktáriám Uycobacterlum (M.) tuborculosis H37Hv> a3 proti atypickým teburkuloznym mykobektériám II. kansasii, II. avlum a M. fortuitumis active against the typical · tuberculous · mycobacteria Uycobacterlum (M.) tuborculosis H 37 H v> and 3 against atypical teburculo-mycobacteria II. Kansasii, II. avlum and M. fortuitum
Súčasne bol zistený spčsob přípravy uvedenej zlúčeniny na báze 6-(2-chlorbanzoylamino)-2-bensotiasolíntiónu. Reakcia sa uskutečňuje alkyláciou draselnéj aoll 6-(2-chlórbenzoylamino)-2-merkaptobenzotlazolu, vznlkajúeej rozpuštění· 6-(2-chlorbonzoylamino)-2-bensotiasolíntiónu v roztoku hydroxidu draselného, alylbrouldom v prostředí zmesi etanol - voda v objemovou pomere 5:1 sa varu po dobu 5 až 15 minút.At the same time, a process for the preparation of said compound based on 6- (2-chlorobenzoylamino) -2-benzothiasolinethione was found. The reaction is carried out by alkylation of potassium aol of 6- (2-chlorobenzoylamino) -2-mercaptobenzotlazole, resulting in the dissolution of 6- (2-chlorobenzoylamino) -2-benzothiasolinethione in a potassium hydroxide solution, allylbrould in a 5: 1 ethanol / water mixture. boil for 5 to 15 minutes.
Nasledujúce příklady blitílo oavetlujú, ala nijako neobmedzujú přípravu zlúčeniny podlá vynálezu.The following examples illustrate, but do not limit, the preparation of a compound of the invention.
PřikladlEXAMPLE
Příprava 2-alyltio-6-(2-chlórbonsoylamlno)bensotiazoluPreparation of 2-allylthio-6- (2-chloro-yoylamino) -bensothiazole
6-(2-chldrbenzoylaaino)-2-bensotlasolíntion (9,6 g, 0,030 mol) oa rozpustil sa varu v roztoku hydroxidu draselného (2,0 g, 0,036 mol) v zmesi vody (20 ml) a etanolu (100 ml). K reakčnej zmesi sa přidal alylbromld (3,65 g, 0,030 mol) a zmes sa udrCiavala ,0 minút pri teplote varu, potom sa odfarblla aktlvnym uhlím a přefiltrovala sa cez vyhrlevaný lievik. Po ochladení na 5 °C vypadol z roztoku krystalický 2-alyltlo-6-(2-chlorbenzoylamlno)benzotiazol s t. t. 115,5 až 117,5 °C v množstve 6,7 g. Zahuštěním matečného lúhu sa sníženáhá tlaku bez sahrievania oa získal Salží podiel 1,6 g produktu rovnakej kvality. Celkový výťažok látky podlá vynálesu činil 8,3 g (76,9 *).6- (2-Chlorobenzoylaaino) -2-benzotlasolinethion (9.6 g, 0.030 mol) and dissolved in boiling in a solution of potassium hydroxide (2.0 g, 0.036 mol) in a mixture of water (20 ml) and ethanol (100 ml) . To the reaction mixture was added allyl bromide (3.65 g, 0.030 mol) and the mixture was kept at reflux for 0 minutes, then decolorized with activated charcoal and filtered through a funnel. After cooling to 5 ° C, crystalline 2-allyltlo-6- (2-chlorobenzoylamino) benzothiazole of m.p. t. 115.5-117.5 ° C in an amount of 6.7 g. Concentration of the mother liquor reduced the pressure without heating to give a salt of 1.6 g of the same quality product. The total yield of the substance according to the invention was 8.3 g (76.9%).
Pre analýzu bola látka přečištěná kryStallsáciou so zmesi etanol - voda v objemovom pomere 4:1 za použitia aktivneho uhlla. Získal sa čistý 2-alýÍtlo-6-(2-chlorbanzoylamino) benzotiazol v podobo žltkasto-bioloj kryStaliekej látky s t.t. 117,5 až 119,5 °C.For analysis, the material was purified by crystallization with ethanol: water (4: 1, v / v) using charcoal. Pure 2-allyl-6- (2-chloro-benzoylamino) -benzothiazole was obtained as a yellowish-bioloy crystals of m.p. 117.5-119.5 ° C.
M. h.: 360,89M. h: 360.89
Pre C,7H13C1N2OS2 vypočítaná: 56,58 » C, 3,63 % H, 9,82 % Cl, 7,76 % N, zistené: 56,37 * 0, 3,57 * H, 9,86 * Cl, 7,66 * N,For C 7 H 13 C1N 2 OS 2 calculated: 56.58 »C, 3.63% H, 9.82% C, 7.76% N Found: 56.37 * 0, 3.57 H, 9.86 * Cl, 7.66 * N,
17,77 « Sj 17,80 » S.17,77 «S 17,80» S.
23943·23943 ·
Pr ík 1 a d 2Example 1 a d 2
Antimykobakterlálna účinnost zlúčeniny podTa vynálezu v porovnáni a účinnoaťou známých antituberkulotlkThe antimycobacterial activity of a compound of the invention in comparison and efficacy of known antituberculosis agents
MIC * minimálna inhibičná koncentrácia vpg/mlMIC * minimum inhibitory concentration in µg / ml
Antimykobakterlálna účinnosť proti tuberkuloznym mykobaktériám bola sledovaná v tekutej Šulovej pftde zrieňovaclm teetom. Ako rozpúšťadlo bol použitý dlmetylsulfoxid.The anti-mycobacterial activity against tuberculous mycobacteria was monitored in liquid granules by dilution teeters. Dimethylsulfoxide was used as solvent.
Výsledná koncentrácia látok v pftde bola 0,25, 0,5, 1, 5, 10, 25, 50 a 100 jig/ml.The final concentration of the substances in the oil was 0.25, 0.5, 1, 5, 10, 25, 50 and 100 µg / ml.
Významný je fakt, že zlúčenina podTa vynálezu svojou účinnoaťou proti atypický· tuberkuloznym mykobaktériám M. fortuitum prevyžuje známe antituberkulotiká (Izoniazid 5-násobné a Etionamid 10-náaobne), přitom je dvojnásobné účinná proti M.avium ako uvedená antituberkulotiká. Zároveň zlúčenina podlá vynálezu sa účinnosťou proti M. kanaasll vyrovnává známým antituberkulotikám (Izoniazidu a Etionamidu) a je vysoko účinná v koncentrácil 10 jig/ml aj proti typickým tuberkuloznym mykobaktériám M. tuberculoals H^R^.Significantly, the compound of the invention outweighs the known antituberculotics (Isoniazid 5-fold and Etionamide 10-fold) by its activity against atypical tuberculous mycobacteria M. fortuitum, while being twice as potent against M.avium as said antituberculotics. At the same time, the compound of the invention is comparable to known antituberculotics (Izoniazide and Etionamide) against M. kanaas11 and is highly active at a concentration of 10 µg / ml and also against typical tuberculous mycobacteria M. tuberculoals H RR ^.
Zlúčeninu podlá vynálezu možno používat ako účinnú zložku antimykobakteřlálnych prípravkov alebo ako medziprodukt pre ňalSie syntézy.The compound of the invention may be used as an active ingredient of antimycobacterial preparations or as an intermediate for further synthesis.
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CS844605A CS239438B1 (en) | 1984-06-18 | 1984-06-18 | 2-alyftio-benzoylamino-672 / benzothiazole |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CS844605A CS239438B1 (en) | 1984-06-18 | 1984-06-18 | 2-alyftio-benzoylamino-672 / benzothiazole |
Publications (2)
Publication Number | Publication Date |
---|---|
CS460584A1 CS460584A1 (en) | 1985-06-13 |
CS239438B1 true CS239438B1 (en) | 1986-01-16 |
Family
ID=5389204
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CS844605A CS239438B1 (en) | 1984-06-18 | 1984-06-18 | 2-alyftio-benzoylamino-672 / benzothiazole |
Country Status (1)
Country | Link |
---|---|
CS (1) | CS239438B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2137750C1 (en) * | 1998-05-19 | 1999-09-20 | Институт органического синтеза Уральского отделения РАН | Substituted di-(formylaryl)-polyesters or their coordination compounds or their pharmaceutically acceptable additive salts, method of their synthesis and pharmaceutical composition on said |
-
1984
- 1984-06-18 CS CS844605A patent/CS239438B1/en unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2137750C1 (en) * | 1998-05-19 | 1999-09-20 | Институт органического синтеза Уральского отделения РАН | Substituted di-(formylaryl)-polyesters or their coordination compounds or their pharmaceutically acceptable additive salts, method of their synthesis and pharmaceutical composition on said |
Also Published As
Publication number | Publication date |
---|---|
CS460584A1 (en) | 1985-06-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69701307T2 (en) | New imidazoline derivatives with imidazoline receptor affinity | |
CS239438B1 (en) | 2-alyftio-benzoylamino-672 / benzothiazole | |
US3027370A (en) | Derivatives of guanidine | |
DE2026997A1 (en) | ||
US2789138A (en) | d-nu-methyl-nu-benzyl-beta-phenyliso-propylamine | |
DE1149010B (en) | Process for the preparation of 1- [2-alkyl-4-aminopyrimidyl- (5) -methyl] -alkylpyridinium salts | |
DE2348577C2 (en) | 1-Amino-4-phenyl-1,2,3,4-tetrahydronaphthalenes, their pharmacologically acceptable salts and pharmaceutical preparations containing them | |
US3113151A (en) | Diguanidine derivatives | |
DE1493822A1 (en) | Process for the preparation of phenylalanine derivatives | |
DE1545969A1 (en) | Process for the preparation of imidazole derivatives | |
DE1211213B (en) | Process for the preparation of 2-imidazolidinones | |
EP0004529A2 (en) | Tantomeric arylaminoimidazoline derivatives, their preparation and pharmaceutical formulations for analgetic application containing them | |
US2877232A (en) | 2-(4-isopentyloxyphenyl)-imino, 3 (4-isopentyloxyphenyl)-thiazolidine and therapeutically useful salts | |
US3657337A (en) | Benzylideneamino guanidines | |
US3723454A (en) | N,n{40 -bis-{8 (1{40 -formamido-2{40 ,2{40 ,2{40 -trichloro)-ethyl{9 -imidazolidines | |
US3751423A (en) | Trichloroethylidene-amino-thiazoles | |
US2797228A (en) | Alkylpyrrole carboxylic acids and derivatives thereof | |
US2726244A (en) | Water-soluble mono-betaine hydrazones of the aminochromes and process of preparing same | |
Joshua | Interaction of 2-Chlorobenzothiazole with Aromatic Thiocarbamides. I. Formation of Guanylthiocarbamides and Sulfides | |
US3026343A (en) | 3, 4 dichloro aminoalkylamides | |
GB864536A (en) | ª‡-ethyl-phenylacetylurea | |
DE2924102A1 (en) | 3-Ergolin-8-yl-1,1-di:ethyl-urea derivs. - useful as dopaminergic stimulants | |
AT237597B (en) | Process for the production of new propylamine derivatives and their salts | |
Blakemore et al. | N-Methyldimaprit (SK&F92054). A chemical control for the histamine H2-receptor agonist dimaprit | |
IL28585A (en) | 3,4-dihalocinnamamides and their use as fungicides |